Business
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
Company announcement – No. 22 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, October 17, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today reports receipt on 16 October 2025 of notification pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholder: As of 15 October 2025, Van H
About this update from Zealand Pharma A/s
[{"type":"image","alt":"Zealand Pharma","displaySize":"","headline":null,"caption":"Zealand Pharma","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":121,"url":"https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6gUCOEdJjLHihlE.VvDQtA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE2OTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff","width":300,"height":121}},"lazy":false},{"type":"text","content":"Company announcement – No. 22 / 2025","length":36,"tagName":"p"},{"type":"text","content":"Zealand Pharma major shareholder announcement: Van Herk Investments B.V.","length":72,"tagName":"p"},{"type":"text","content":"Copenhagen, Denmark, October 17, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today reports receipt on 16 October 2025 of notification pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholder:","length":361,"tagName":"p"},{"type":"text","content":"As of 15 October 2025, Van Herk Investments B.V. (Dutch registration no. 59055057) holds nominally 7,143,305 shares (each share carrying one vote) in Zealand Pharma A/S, corresponding to 10.01% of the total share capital and 10.01% of the total voting rights in Zealand Pharma A/S.","length":287,"tagName":"p"},{"type":"text","content":"Van Herk Investments B.V. is 100% owned by Van Herk Investments THI B.V., which is 100% owned by Van Herk Private Equity Investments B.V. (Dutch registration no. 58894543). Ultimately, Van Herk Private Equity Investments B.V. is owned and controlled by Mr. Adrianus van Herk.","length":275,"tagName":"p"},{"type":"text","content":"Van Herk Management Services B.V. (Dutch registration no. 24377325) controls and exercises the voting rights on behalf of Van Herk Investments B.V., and accordingly, Van Herk Management Services B.V controls and exercises the voting rights on nominally 7,143,305 shares (each share carrying one vote), corresponding to 10.01% of the total share capital and 10.01% of the total voting rights in Zealand Pharma A/S.","length":413,"tagName":"p"},{"type":"text","content":"Van Herk Management Services B.V., is controlled by OGBB A. van Herk B.V...